drugset / Trial / NCT04171349
Articaine vs Dexmedetomidine Supplemented Articaine
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block
Timeline
- Start
- 2019-06-01
- Primary completion
- 2019-10-01
- Completion
- 2019-11-01
Outcome
Met primary endpoint
paper Longer sensory block duration was in Group AD (230-260 min) than in Group A (172-185 min) with P < 0.001. PMID 33487824 ↗
paper In addition, motor block duration was significantly longer in Group AD than in Group A PMID 33487824 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Articaine | Other / unclassified | 2 % | Other |
| Subject | Articaine | Other / unclassified | 40 ml | Other |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Other |